Melody-Niki S.
- Country
- Sweden
- Department
- Studieenheten, Akademiskt specialistcentrum (SLSO) Dalagatan 9 113 61 Stockholm Sweden
Research Overview
- Efficacy and Safety Evaluation of Deucravacitinib in Adults with Active Sjögren's Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Efgartigimod Alfa Subcutaneous Injection in Adult Patients with Primary Sjögren’s Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 20 of 126 partner sites.
Specializations
Rheumatology and autoimmune disease
The investigator’s clinical research interest includes inflammatory disorders such as rheumatoid arthritis, polymyalgia rheumatica, Sjögren’s syndrome, and microscopic colitis, with attention to immune-mediated disease control and symptom burden.
- Rheumatoid arthritis
- Polymyalgia rheumatica
- Sjögren’s syndrome
- Microscopic colitis
Additional therapeutic interest extends to immune-targeted treatment strategies aimed at reducing systemic inflammation and improving disease-specific outcomes.
Neurology and neuroinflammatory disorders
Clinical involvement spans multiple sclerosis, relapsing multiple sclerosis, progressive multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s disease, progressive supranuclear palsy, and chronic inflammatory demyelinating polyneuropathy.
- Multiple sclerosis
- Amyotrophic lateral sclerosis
- Parkinson’s disease
- Chronic inflammatory demyelinating polyneuropathy
The therapeutic focus includes neurodegenerative and demyelinating conditions where disease progression, disability, and long-term neurological function are central concerns.
Endocrinology and metabolic disease
Research activity also covers type 1 diabetes mellitus, type 2 diabetes mellitus, obesity, hypertriglyceridemia, chronic kidney disease, and cardiovascular disease linked to metabolic risk.
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus
- Obesity
- Chronic kidney disease
Interest in this area centers on glucose regulation, metabolic control, and prevention of organ complications associated with long-standing metabolic disease.
Psychiatry and mental health
The investigator is involved in studies of major depressive disorder, depression, bipolar I mania, schizophrenia spectrum disorder, and opioid use disorder, reflecting a broad psychiatric therapeutic portfolio.
- Major depressive disorder
- Bipolar I disorder
- Schizophrenia spectrum disorder
- Opioid use disorder
Key clinical interests include mood symptoms, psychosis, substance dependence, and treatment-resistant psychiatric conditions.
Respiratory, infectious, and general internal medicine
Additional trial involvement includes asthma, chronic obstructive pulmonary disease, respiratory syncytial virus, human metapneumovirus, diabetic foot ulcer, and heart failure prevention.
- Asthma
- Chronic obstructive pulmonary disease
- Respiratory syncytial virus
- Diabetic foot ulcer
This area reflects interest in chronic airway disease, infection prevention, wound healing, and cardiometabolic risk reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.